IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minden, P.
Right arrow Articles by Farr, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minden, P.
Right arrow Articles by Farr, R. S.

 Previous Article  |  Next Article 

Infect Immun. 1971 April; 3(4): 524-529
Copyright © 1971 American Society for Microbiology. All Rights Reserved.

Antigenic Differences Between Mycobacterium bovis Strain BCG and an Isoniazid-Resistant Mutant

Percy Minden, J. Kenneth McClatchy, Emil J. Bardana Jr. and Richard S. Farr

Departments of Allergy and Clinical Immunology and Clinical Laboratories, National Jewish Hospital and Research Center, Denver, Colorado 80206

ABSTRACT

The antigenicities of Mycobacterium bovis strain BCG and an isoniazid (INH) - resistant mutant were compared. Sonic extracts of heat-killed, washed bacteria were injected into rabbits, and antisera were produced (anti-BCG and anti-BCG-R). The sonic extracts were also subjected to ultracentrifugation, and test antigens were prepared from the resulting supernatants (BCG and BCG-R). The antigens were labeled with 131I, and the antisera were tested for their capacity to bind 131I-BCG and 131I-BCG-R by precipitating 131I-antigen-antibody complexes with anti-rabbit gamma globulin. Significant differences were detected between the two test antigens. Immunodiffusion studies with unabsorbed antisera and antisera absorbed with BCG and BCG-R suggested that an antigenic component in BCG is lacking or diminished in BCG-R and that anti-BCG has antibodies not found in anti-BCG-R. These quantitative and qualitative differences were confirmed by inhibition studies. Complete inhibition was achieved in all systems by both test antigens when either was added in sufficient concentration. As expected, BCG-R inhibited the binding of 131I-BCG-R by anti-BCG-R or anti-BCG (or both) to a greater extent than BCG, and BCG was a better inhibitor in an 131I-BCG-anti-BCG-R system. However, in an 131I-BCG-anti-BCG test system, BCG was the better inhibitor only at high concentrations. It was concluded that the test antigens possess different proportions of identical or cross-reacting components and that INH-sensitive organisms possess a component(s) that is diminished or absent in the INH-resistant mutant. Whether this component(s) is responsible for INH-resistance is not known.


Infect Immun. 1971 April; 3(4): 524-529
Copyright © 1971 American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 1971 by the American Society for Microbiology. All rights reserved.